🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Aspirin 100 mg OD plus clopidogrel 75 mg OD

Found 13 matching trials

The Switching Antiplatelet-9 (SWAP-9) Study

PHASE4

The purpose of this study is to compare the pharmacodynamic effects of ABCD...

Status

Recruiting

Location

University of Florida

Start Date

2024-11-01

Trial ID

NCT06588595

Treatments Being Tested

Prasugrel/Ticagrelor monotherapy or aspirin plus clopidogrel Aspirin plus clopidogrel

STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT

Primary percutaneous coronary intervention (PCI) is the preferred revascula...

Status

Recruiting

Location

Geneva University Hospitals

Start Date

2025-11-01

Trial ID

NCT05785897

Treatments Being Tested

Successful primary PCI, defined as primary PCI of the culprit lesion with ≥1 Abluminus NP polymer-free sirolimus-based nanocarrier eluting stent (Concept Medical Inc., India) implantation

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

PHASE3

To assess whether a rivaroxaban-based anticoagulation strategy, following s...

Status

Terminated

Location

Multiple Locations

Start Date

2015-12-16

Trial ID

NCT02556203

Treatments Being Tested

Rivaroxaban (Xarelto, BAY59-7939)Acetylsalicylic Acid (ASA)Clopidogrel Rivaroxaban (Xarelto, BAY59-7939)Vitamin K antagonist (VKA)

Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus

PHASE4

Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibito...

Status

Completed

Location

University of Florida

Start Date

2016-03-25

Trial ID

NCT02548650

Treatments Being Tested

Vorapaxar Clopidogrel Aspirin

Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)

The management of patients with unprotected left main coronary artery (LMCA...

Status

Recruiting

Location

Zurich University Hospital

Start Date

2026-04-26

Trial ID

NCT05650411

Treatments Being Tested

LMCA PCI with Supraflex Cruz ultrathin-strut biodegradable polymer sirolimus-eluting stent (Sahajanand Medical Technologies Ltd., Surat, India).P2Y12 inhibitor-based SAPT after short DAPT Conventional DAPT

Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel

PHASE4

It is not uncommon that patients requiring dual antiplatelet therapy (DAPT)...

Status

Completed

Location

University of Florida

Start Date

2016-03

Trial ID

NCT02567461

Treatments Being Tested

Edoxaban 60 mg Edoxaban 30 mg Clopidogrel 75 mg Aspirin 81 mg

Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)

PHASE3

The aortic valve is located between the left ventricle and the aorta. Patie...

Status

Completed

Location

Cedars Sinai Medical Center

Start Date

2016-05

Trial ID

NCT02833948

Treatments Being Tested

Acetylsalicylic acid Clopidogrel Rivaroxaban

Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease

In the proposed event driven trial, LAA closure devices will be compared in...

Status

Recruiting

Location

Universität zu Lübeck

Start Date

2022-03-28

Trial ID

NCT05204212

Treatments Being Tested

Left Atrial Appendage closure

Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study

PHASE3

The study will perform a randomized, head-to-head comparison between SAPT (...

Status

Unknown

Location

Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ospedaliero G. Rodolico

Start Date

2021-06-14

Trial ID

NCT05554822

Treatments Being Tested

Aspirin 100mg Aspirin 100 mg OD plus clopidogrel 75 mg OD

Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)

PHASE3

The purpose of this study is to determine if the combination of clopidogrel...

Status

Completed

Location

Sanofi-Aventis Administrative Office

Start Date

2003-06

Trial ID

NCT00249873

Treatments Being Tested

clopidogrel (SR25990C)placebo

Previous Next